| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.095 | 0.005 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.098 | 0.006 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.006 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.008 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.094 | 0.008 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.008 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.17 | 0.009 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |